Archives
-
TCAIM Control of OGDH and Mitochondrial Metabolism
2026-08-24
The 2025 Molecular Cell study identifies TCAIM as a mitochondrial DNAJC co-chaperone that specifically binds native OGDH and promotes its reduction through HSPA9 and LONP1. This mechanism links mitochondrial proteostasis to control of OGDH complex activity and carbohydrate catabolism, offering a new framework for studying post-translational metabolic regulation.
-
Phenacetin as a PK Reference in Translational Assays
2026-08-24
Phenacetin offers a chemically defined reference point for pharmacokinetic studies, solubility assessment, and translational assay design. This article distinguishes its value as a workflow control from the target-specific biology of emerging PDK4 inhibitors.
-
UTP Solution (100 mM) for RNA Workflows
2026-08-23
UTP Solution (100 mM) provides a contamination-controlled uridine nucleotide input for in vitro transcription, RNA amplification, siRNA synthesis, and selected nucleotide-metabolism assays. This guide connects practical reagent handling with the TRIM66 olfactory-receptor study, showing how robust RNA production can support mechanistic and low-input experiments without overstating what the nucleotide itself proves.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-22
The 2025 study shows that naturally occurring angiotensin fragments can enhance SARS-CoV-2 spike-protein binding to host receptors, with effects determined by peptide length, terminal sequence, and tyrosine modification. Its antibody-based binding design provides a useful framework for connecting renin-angiotensin system research with viral receptor biology while emphasizing that biochemical binding is not equivalent to demonstrated infection or clinical risk.
-
Deferoxamine Mesylate in Ferroptosis Workflows
2026-08-22
Deferoxamine mesylate gives researchers a practical way to manipulate labile iron while separating iron-dependent lipid damage from plasma-membrane execution events. This guide shows how to use it as a ferroptosis rescue control, hypoxia-mimetic reagent, and oxidative stress protection tool without confusing chelation with TMEM16F inhibition.
-
Angiotensin I/II (1-5): RAS Workflow Guide
2026-08-21
Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure, renal, and aldosterone-related readouts. It is intended for cardiovascular and renal workflows, not general peptide-signaling studies, and its water insolubility requires deliberate solvent, vehicle, and storage controls.
-
RNAi Screen Reveals SARS-CoV-2 Release Factors
2026-08-20
Kerr et al. developed an arrayed, druggable-genome RNA interference screen that measures SARS-CoV-2 production at multiple stages, reducing the bias toward early replication factors. The study identifies Rab11a-linked vesicular transport as a conserved proviral pathway and shows that CDK9 inhibitor-73 can block viral release, supporting further investigation of host-directed antiviral mechanisms.
-
Baicalein in Redox-Aware Cancer Assays
2026-08-20
Baicalein is a 12-LOX-inhibiting flavonoid for dissecting cancer, apoptosis, and inflammatory signaling. This guide builds beyond standard mechanism summaries by showing how to pair pathway engagement with orthogonal redox and cell-selectivity assays.
-
IGFBP2–THBS1 Mechanism in GH-Treated ISS
2026-08-19
The reference study identifies an IGFBP2–THBS1 regulatory axis that links growth hormone treatment to IGF-1 signaling, chondrocyte proliferation, and hypertrophic differentiation in idiopathic short stature. Its perturbation experiments suggest that IGFBP2 is more than a biomarker: it is a functional mediator that may help explain variable responses to somatotropin therapy and guide future mechanistic studies.
-
HyperScript First-Strand cDNA Synthesis Kit for Stress RNA
2026-08-19
Convert structurally challenging or scarce plant RNA into cDNA suited for PCR amplification and qPCR reaction workflows. The HyperScript First-Strand cDNA Synthesis Kit combines primer flexibility with a thermally stable, RNase H-reduced reverse transcriptase for transcriptomics validation and low-copy gene reverse transcription.
-
Biotin-tyramide: Practical TSA Workflows
2026-08-18
Biotin-tyramide converts target-bound HRP into a localized amplification engine for demanding IHC and ISH assays. This guide connects reagent handling, assay controls, and troubleshooting with the spatial-RNA perspective of Halo-seq, while clearly separating compatible imaging workflows from non-interchangeable transcriptome methods.
-
ATP Solution for mRNA and Kinase Workflows
2026-08-18
A ready-to-use 100 mM ATP reagent supports reproducible in vitro transcription, kinase, ligation, and phosphorylation workflows. This practical guide connects ATP-dependent assay control with p21 mRNA–LNP research while separating validated study findings from recommended optimization conditions.
-
Cabozantinib Blocks MLKL Oligomerization in Psoriasis
2026-08-17
The reference study identifies cabozantinib as a repurposed inhibitor of necroptosis that acts at the MLKL oligomerization stage rather than primarily blocking upstream RIPK1 or RIPK3 signaling. In an imiquimod-induced psoriasis model, this mechanism was associated with reduced epidermal hyperplasia and inflammatory cytokine expression, providing a rationale for mechanism-guided drug repositioning screening in inflammatory disease.
-
DAMGO: µ-Opioid Receptor Agonist Workflows
2026-08-17
DAMGO enables controlled interrogation of µ-opioid receptor signaling from membrane assays to central pain circuits. This workflow-oriented guide shows how to connect receptor activation, mechanical hypersensitivity, and tolerance models while avoiding common interpretation and handling errors.
-
Bleomycin Sulfate: From DNA Breaks to Fibrosis
2026-08-16
Bleomycin Sulfate, also recognized in clinical literature as Blenoxane, is more than a DNA-damaging compound. Its metal-dependent oxidative chemistry creates a translational bridge between oncology, pulmonary fibrosis research, and emerging studies of tissue-specific fibrotic signaling.